http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2079482-C
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-065 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-06 |
filingDate | 1991-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2004-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f7d3fd9a3d8cdae41632a202fd1f667 |
publicationDate | 2004-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2079482-C |
titleOfInvention | Antiviral compositions and method for their use |
abstract | Compositions having significant activity as antiviral agent are disclosed containing, as an active component, a compound having the structural formula (I) wherein R1 and R1' are the same or different and each is an alkyl group, a phenyl group or a substituted derivative of a phenyl group; wherein R2 and R2' are the same or different and each is hydrogen, an unbranched alkyl group, a halide or a group having the structure (a) wherein R is hydrogen, an alkoxide group, an alkyl group, or OH; wherein R3 and R3' are the same or different and each is hydrogen or an alkyl group; wherein X and X' are the same or different and each is a water soluble group having weak to intermediate ligand field strength; and Q' is a soluble, pharmaceutically acceptable negative ion. Methods of use of the inventive compositions are also disclosed. |
priorityDate | 1990-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.